Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker.
about
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigenA review of the past, present, and future directions of neoplasiaComing of Age in the Life ofNeoplasia: Where We Have Been and Where We Are GoingMagnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland.Longitudinal diffusion tensor imaging in a rat brain glioma modelStudies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.High-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal modelDiffusion-weighted MRI for monitoring tumor response to photodynamic therapy.Focal therapy in the management of prostate cancer: an emerging approach for localized prostate cancer.Animal models of extracranial pediatric solid tumorsDeformable and rigid registration of MRI and microPET images for photodynamic therapy of cancer in mice.Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer.Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma.Photosensitizers in prostate cancer therapy.In Vivo Small Animal Imaging for Early Assessment of Therapeutic Efficacy of Photodynamic Therapy for Prostate Cancer.Treatment of canine osseous tumors with photodynamic therapy: a pilot study.Homologous adaptation to oxidative stress induced by the photosensitized Pd-bacteriochlorophyll derivative (WST11) in cultured endothelial cells.
P2860
Q24647328-5AEF1895-AA60-4772-AAFE-C7AB8C4DAB3BQ28389391-22B25DAA-4C26-4973-B9AC-7530284B5A77Q28389985-5522EB67-7A0B-49C1-A39E-24EC3A5B06B8Q28395095-419775E6-7790-437B-A777-24EF17C8EE20Q30819296-F8FD32B5-0D14-4402-A0F2-1DD43C8C69AAQ31155125-B66F9741-4AEA-42D2-BD76-6CDAB4995EE6Q33214458-2B26A7A5-847C-4E43-AAE4-2E4C55F6F2BAQ33303889-BFA28CB6-C060-4F3C-AFAD-8298FE5E63A5Q33647190-DF82C96E-DD84-4652-B017-EFD42A8B9F2DQ35944856-D614F309-2342-41A2-B94B-F2B3EEDE977AQ36403149-E60C2EDC-E4F5-4CAF-85F8-80017C1B5E43Q36551652-48968F6D-E3EF-45B3-BD09-01C15A40319AQ36866123-75FEC750-9269-4C26-96E7-9A04B8CD107BQ37667736-B3A397F3-B55D-4BA9-AA5F-C18241DEBC7CQ39254736-DA1C5C83-BA75-4039-9B51-E3171D1B6B51Q41808278-27D43BF0-09DC-4B01-990A-F117F60DF828Q41983616-F0C3B2AF-B756-4CEE-8667-94F1E95C7044Q45038660-27F629CC-FF8E-4316-9402-FDB65DFE4DB5
P2860
Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Photodynamic therapy of establ ...... ial early MRI response marker.
@en
type
label
Photodynamic therapy of establ ...... ial early MRI response marker.
@en
prefLabel
Photodynamic therapy of establ ...... ial early MRI response marker.
@en
P2093
P2860
P356
P1433
P1476
Photodynamic therapy of establ ...... ial early MRI response marker.
@en
P2093
Avigdor Scherz
Hannah Kanety
Jacob Ramon
Jehonathan H Pinthus
Michal Neeman
Natalia Koudinova
Vicki Plaks
Yoram Salomon
Zelig Eshhar
P2860
P304
P356
10.1593/NEO.03352
P577
2004-05-01T00:00:00Z